TRxADE HEALTH Inc.

NASDAQ: MEDS · Real-Time Price · USD
7.59
0.33 (4.55%)
At close: Sep 20, 2024, 10:00 PM

TRxADE HEALTH Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
136.64K 8.27M 11.45M 9.89M
Cost of Revenue
130.64K 5.67M 6M 5.14M
Gross Profit
6K 2.6M 5.45M 4.75M
Operating Income
-18.78M -7.26M -2.76M -5.29M
Interest Income
135.34K 4.2K 20.99K n/a
Pretax Income
9.6M -13.72M -3.91M -5.32M
Net Income
9.07M -17.84M -4.31M -4.11M
Selling & General & Admin
8.14M 8.48M 7.05M 8.81M
Research & Development
2.24M 1.38M 1.16M 1.37M
Other Expenses
4.2M n/a n/a -1.23M
Operating Expenses
14.58M 9.86M 8.21M 8.81M
Interest Expense
-1.34M 1.2M 336.21K 23.59K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
14.71M 15.54M 14.2M 13.96M
Income Tax Expense
534.4K n/a 400.34K -1.2M
Shares Outstanding (Basic)
3.38M 764.06K 564.86K 542.45K
Shares Outstanding (Diluted)
3.65M 764.06K 564.86K 542.45K
EPS (Basic)
2.69 -23.35 -7.63 -7.58
EPS (Diluted)
2.48 -7.49 -7.63 -7.58
EBITDA
-18.78M -6.21M -1.85M -5.15M
EBIT
n/a -12.52M -2.07M -5.29M
Depreciation & Amortization
n/a 1.05M 194.7K 138.91K